Entrectinib in patients with NTRK fusion-positive solid tumors or ROS1-positive NSCLC with CNS metastases
Paz-Ares, L Dziadziuszko, R Drilon, A John, T Krebs, Matthew G Demetri, G Shaw, AT Siena, S Wolf, J Farago, AF
Paz-Ares, L
Dziadziuszko, R
Drilon, A
John, T
Krebs, Matthew G
Demetri, G
Shaw, AT
Siena, S
Wolf, J
Farago, AF
Citations
Altmetric:
Abstract
Description
Date
2020
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Overbeck T, Siena S, Doebele RC, Shaw AT, Karapetis CC, Tan DSW, et al. Efficacy of Entrectinib in Patients (PTS) with Solid Tumors and Central Nervous System (CNS) Metastases: Integrated Analysis from 3 Clinical Trials. Oncology Research and Treatment. 2020;43:34-5